The UMD-FBN1 mutations database
Record ID: 3

Mutation description


Variation name (cDNA level)Variation name (protein level)Variation statusVariation class
c.3746G>Cp.Cys1249SerHeterozygousMutation

wt codonwt aamutant codonmutant aamutational eventmutation type
TGTCysTCTSerG->CTv

StructureKey Residue (HCD)Pyrimidin doubletCpG
cb EGF-like #16 Disulfide bonds 1249-1263 (C2)NoNo

Mutation impact


At the mRNA levelOn restriction map
NANew restriction site(s): none
Lost restriction site(s): none

Conservation (0-1)SIFT (0-1)UMD-predictor (0-100)
0.830.00 (pathogenous)82 (Pathogenous)

Patient and sample data


Sample IDPatient statusGenderTransmissionAge of onsetAge of deathGeographic origin
USA01BAL F0003 I04ProbandFemalede novoin childhoodU.S.A

Phenotypic groupDisease
Type IVClassical MFS

Clinical data


SymptomSeverity
C-Asc. aortic dilatation
C-Mitral valve prolapse
O-Ectopia lentis
O-Myopia
S-Arachnodactyly (M)
S-Dolichostenomelia
S-Long bone over growth
S-Scoliosis > 20° (M)(1)

Reference


Reference IDPubMed IDReference
21301946
Dietz HC, Saraiva JM, Pyeritz RE, Cutting GR, Francomano CA. "Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains". Hum Mutat 1992;1(5):366-74.